A Novel Approach for Non-Invasive Continuous In-Line Control of Perfusion Cell Cultivations by Raman Spectroscopy.
CHO perfusion process
Raman spectroscopy
automated glucose control
continuous manufacturing
process analytical technologies (PAT)
quality by design (QbD)
Journal
Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
06
2021
accepted:
04
04
2022
entrez:
13
5
2022
pubmed:
14
5
2022
medline:
14
5
2022
Statut:
epublish
Résumé
Continuous manufacturing is becoming more important in the biopharmaceutical industry. This processing strategy is favorable, as it is more efficient, flexible, and has the potential to produce higher and more consistent product quality. At the same time, it faces some challenges, especially in cell culture. As a steady state has to be maintained over a prolonged time, it is unavoidable to implement advanced process analytical technologies to control the relevant process parameters in a fast and precise manner. One such analytical technology is Raman spectroscopy, which has proven its advantages for process monitoring and control mostly in (fed-) batch cultivations. In this study, an in-line flow cell for Raman spectroscopy is included in the cell-free harvest stream of a perfusion process. Quantitative models for glucose and lactate were generated based on five cultivations originating from varying bioreactor scales. After successfully validating the glucose model (Root Mean Square Error of Prediction (RMSEP) of ∼0.2 g/L), it was employed for control of an external glucose feed in cultivation with a glucose-free perfusion medium. The generated model was successfully applied to perform process control at 4 g/L and 1.5 g/L glucose over several days, respectively, with variability of ±0.4 g/L. The results demonstrate the high potential of Raman spectroscopy for advanced process monitoring and control of a perfusion process with a bioreactor and scale-independent measurement method.
Identifiants
pubmed: 35547168
doi: 10.3389/fbioe.2022.719614
pii: 719614
pmc: PMC9081366
doi:
Types de publication
Journal Article
Langues
eng
Pagination
719614Informations de copyright
Copyright © 2022 Graf, Lemke, Schulze, Soeldner, Rebner, Hoehse and Matuszczyk.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Biotechnol Bioeng. 2022 Feb;119(2):423-434
pubmed: 34778948
Biotechnol Prog. 2019 Sep;35(5):e2848
pubmed: 31115976
Biotechnol Prog. 2015 Jul-Aug;31(4):1026-38
pubmed: 25857574
Appl Spectrosc. 2009 Aug;63(8):936-40
pubmed: 19678992
Biotechnol J. 2018 Jan;13(1):
pubmed: 28862393
Talanta. 2019 Jul 1;199:396-406
pubmed: 30952275
Biotechnol Prog. 2021 Jan;37(1):e3074
pubmed: 32865874
Biotechnol Prog. 2017 Mar;33(2):337-346
pubmed: 28271638
Sensors (Basel). 2019 Feb 15;19(4):
pubmed: 30781431
J Biotechnol. 2015 Nov 10;213:120-30
pubmed: 26091773
Biotechnol Prog. 2016 Jan-Feb;32(1):224-34
pubmed: 26587969
Biotechnol Bioeng. 2017 Feb;114(2):298-307
pubmed: 27497430
Biotechnol Prog. 2018 Nov;34(6):1574-1580
pubmed: 30281947
Anal Bioanal Chem. 2017 Jan;409(3):637-649
pubmed: 27491299
Appl Spectrosc. 2017 Jun;71(6):1085-1116
pubmed: 28534676
Biotechnol Bioeng. 2015 Apr;112(4):648-51
pubmed: 25694022
Nat Biotechnol. 2018 Dec 6;36(12):1136-1145
pubmed: 30520869
Anal Chim Acta. 2013 Sep 24;796:84-91
pubmed: 24016587
Biotechnol Prog. 2019 Mar;35(2):e2757
pubmed: 30479066